The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis
BACKGROUND: Previous evidence synthesis has suggested diabetes mellitus (DM)
worsens tuberculosis (TB) treatment outcomes. However, these reviews are limited by the …
worsens tuberculosis (TB) treatment outcomes. However, these reviews are limited by the …
Management of patients with multidrug-resistant tuberculosis
C Lange, RE Aarnoutse, JWC Alffenaar… - … of tuberculosis and …, 2019 - ingentaconnect.com
The emergence of multidrug-resistant tuberculosis (MDR-TB; defined as resistance to at
least rifampicin and isoniazid) represents a growing threat to public health and economic …
least rifampicin and isoniazid) represents a growing threat to public health and economic …
The emerging role of myeloid-derived suppressor cells in tuberculosis
T Magcwebeba, A Dorhoi, N du Plessis - Frontiers in immunology, 2019 - frontiersin.org
Myeloid cells are crucial for the host control of a Mycobacterium tuberculosis (M. tb)
infection, however the adverse role of specific myeloid subsets has increasingly been …
infection, however the adverse role of specific myeloid subsets has increasingly been …
Coprevalence of type 2 diabetes mellitus and tuberculosis in low‐income and middle‐income countries: a systematic review
HS McMurry, E Mendenhall… - Diabetes/metabolism …, 2019 - Wiley Online Library
Increasing coprevalence of diabetes mellitus (DM) and tuberculosis (TB) in low‐income and
middle‐income countries (LMICs) indicates a rising threat to the decades of progress made …
middle‐income countries (LMICs) indicates a rising threat to the decades of progress made …
[HTML][HTML] Forecasting the impact of diabetes mellitus on tuberculosis disease incidence and mortality in India
Background In context of the rapidly expanding diabetes mellitus (DM) epidemic in India and
slowly declining tuberculosis (TB) incidence, we aimed to estimate the past, current, and …
slowly declining tuberculosis (TB) incidence, we aimed to estimate the past, current, and …
Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co‐morbidity
Alteration in the frequency of monocyte subsets is a hallmark of tuberculosis–diabetes co‐
morbidity (TB‐DM). To study this association, we examined the plasma levels of sCD 14 …
morbidity (TB‐DM). To study this association, we examined the plasma levels of sCD 14 …
Immunometabolism and pulmonary infections: implications for protective immune responses and host-directed therapies
The biology and clinical efficacy of immune cells from patients with infectious diseases or
cancer are associated with metabolic programming. Host immune-and stromal-cell genetic …
cancer are associated with metabolic programming. Host immune-and stromal-cell genetic …
Burden and characteristics of the comorbidity tuberculosis—diabetes in Europe: TBnet prevalence survey and case-control study
M Sane Schepisi, A Navarra… - Open forum …, 2019 - academic.oup.com
Background The growing burden of diabetes mellitus (DM) is posing a threat to global
tuberculosis (TB) control. DM triples the risk of developing TB, modifies the presenting …
tuberculosis (TB) control. DM triples the risk of developing TB, modifies the presenting …
Diabetes in active tuberculosis in low-income countries: to test or to take care?
Tuberculosis and diabetes are a topical example of an association between communicable
and noncommunicable diseases. These diseases are mutually linked, increasing each …
and noncommunicable diseases. These diseases are mutually linked, increasing each …
Point of care HbA1c level for diabetes mellitus management and its accuracy among tuberculosis patients: a study in four countries
BACKGROUND: Diabetes mellitus (DM) is common among tuberculosis (TB) patients and
often undiagnosed or poorly controlled. We compared point of care (POC) with laboratory …
often undiagnosed or poorly controlled. We compared point of care (POC) with laboratory …